Anti-CD73 monoclonal antibody–drug conjugate that binds and inhibits CD73 (ecto-5′-nucleotidase), reducing extracellular adenosine and associated A2A/A2B receptor–mediated immunosuppression, while delivering the topoisomerase I–inhibiting payload SN38 to CD73-expressing cells to induce DNA damage and apoptosis.